757
Views
31
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

A multicentre, prospective, randomized, controlled study to evaluate the use of a fibrin sealant as an adjunct to sutured dural repair

, , , , , , , , & show all
Pages 11-17 | Received 10 Feb 2014, Accepted 21 Jul 2014, Published online: 12 Aug 2014

References

  • Horowitz G, Fliss DM, Margalit N, Wasserzug O, Gil Z. Association between cerebospinal fluid leak and meningitis after skull base surgery. Otolaryngol Head Neck Surg 2011;145:689–93.
  • Cosgrove GR, Delashaw JB, Grotenhuis JA, et al. Safety and effectiveness of a novel polyethylene glycol hydrogel sealant for watertight dural closure. J Neurosurg 2007;106:52–8.
  • Esposito F, Cappabianca P, Fusco M, et al. Collagen-only biomatrix as a novel dural substitute examination of the efficacy, safety and outcome: clinical experience on a series of 208 patients. Clin Neurol NeuroSurg 2008;110:343–51.
  • Gaberel T, Borgey F, Thibon P, et al. Surgical site infection associated with the use of bovine serum albumin-glutaraldehyde surgical adhesive (Bioglue®) in cranial surgery: a case control study. Acta Neurochir 2011;153:156–63.
  • Nagata K, Kawamoto S, Sashida J, et al. Mesh-and-glue technique to prevent leakage of cerebrospinal fluid after implantation of expanded polytetrafluoroethylene dura substitute. Neurol Med Chir 1999;39:316–9.
  • Osbun JW, Ellenbogen RG, Chesnut RM, et al. A multicenter, single-blind, prospective randomized trial to evaluate the safety of a polyethylene glycol hydrogel (Duraseal Dural Sealant System) as a dural sealant in cranial surgery. World Neurosurg 2012;78: 498–504.
  • San-Galli F, Deminiere C, Guerin J, Rabaud M. Use of a biodegradable elastin-fibrin material Neuroplast®, as a dural substitute. Biomaterials 1996;17:1081–5.
  • von Wild KR. Examination of the safety and efficacy of an absorbable dura matter substitute (Dura Patch®) in normal applications in neurosurgery. Surg Neurol 1999;52:418–25.
  • Atkinson JB, Gomperts ED, Kang R, et al. Prospective, randomized evaluation of the efficacy of fibrin sealant as a topical hemostatic agent at the cannulation site in neonates undergoing extracorporeal membrane oxygenation. Am J Surg 1997;173:479–84.
  • Hida K, Yamaguchi S, Seki T, et al. Nonsuture dural repair using polyglycolic acid mesh and fibrin glue:clinical application to spinal surgery. Surg Neurol 2006;65:136–43.
  • Jankowitz BT, Atteberry DS, Gerszten PC, et al. Effect of fibrin glue on the prevention of the persistent cerebral spinal fluid leakage after incidental durotomy during lumbar spinal surgery. Eur Spine J 2009;18:1169–1174.
  • Schwartz M, Madariaga J, Hirose R, et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004;139:1148–54.
  • Wang GJ, Hungerford DS, Savory CG, et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 2001;83:1503–5.
  • Yoshimoto T, Sawanmure Y, Houkin K, Abe H. Effectiveness of fibrin glue for preventing postoperative extradural fluid leakage. Neurol Med Chir 1997;37:886–90.
  • Chalmers RT, Darling RC, Wingard JT, et al. Randomised clinical trial of tranexamic acid-free fibrin sealant during vascular surgical procedures. Br J Surg 2010;97:1784–9.
  • Hutchinson RW, Mendenhall V, Abutin RM, Muench T, Hart J. Evaluation of fibrin sealants for central nervous system sealing in the mongrel dog durotomy model. Neurosurgery 2011;69:921–9.
  • ICH Expert Working Group. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice E6(R1). Current Step 4 version. 10 June 1996. http://www.who.int/vaccine_research/ICH_GCP.pdf
  • World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 2001. http://www.wma.net/en/30publications/10policies/b3/index.
  • Dubey A, Wen-Shan S, Shaya, M, et al. Complications of posterior cranial fossa surgery—an institutional experience of 500 patients. Surg Neurol 2009;72:369–75.
  • Whitehead J. The Design and Analysis of Sequential Clinical Trials. Revised Second edition. Chichester: John Wiley & Sons, 1997.
  • Grotenhuis JA. Costs of postoperative cerebrospinal fluid leakage: 1-year, retrospective analysis of 412 consecutive nontrauma cases. Surg Neurol 2005;64:490–3.
  • Kim KD, Wright NM. Polyethylene glycol hydrogel spinal sealant (DuraSeal Spinal Sealant) as an adjunct to sutured dural repair in the spine: results of a prospective, multicenter, randomized controlled study. Spine 2011;36:1906–12.
  • Steinbok P, Singhal A, Mills J, Cochrane DD, Price AV. Cerebrospinal fluid (CSF) leak and pseudomeningocele formation after posterior fossa tumor resection in children: a retrospective analysis. Childs Nerv Syst 2007;23:171–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.